A CONJUGATE OF A TUBULYSIN ANALOG WITH BRANCHED LINKERS
申请人:Hangzhou DAC Biotech Co., Ltd.
公开号:US20200276261A1
公开(公告)日:2020-09-03
The present invention relates to the conjugation of a tubulysin analog compound to a cell-binding molecule with branched/side-chain linkers for having better delivery of the conjugate compound and targeted treatment of abnormal cells. It also relates to a branched-linkage method of conjugation of a tubulysin analog molecule to a cell-binding ligand, as well as methods of using the conjugate in targeted treatment of cancer, infection and autoimmune disease.